Prasco LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Prasco LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7535
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥68,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥102,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Prasco LLC (Prasco Laboratories) is a pharmaceutical company that manufactures and markets authorized generic and generic products. The company’s authorized generic products include acitretin capsules, clotrimazole and betamethasone dipropionate cream, atovaquone and proguanil HCl tablets, calcipotriene cream, and carbamazepine extended-release capsules. It also provides augmented betamethasone dipropionate, levalbuterol HCl inhalation solution, mirtazapine orally disintegrating tablets and mupirocin calcium cream, among others. Prasco Laboratories’ generic products comprise duloxetine delayed release capsules, olanzapine orally disintegrating tablets, raloxifene Hcl, pantoprazole sodium delayed-release tablets, and olanzapine tablets. The company partners with various pharmaceutical companies for manufacturing authorized generic products. It has operations in Cincinnati and Washington D.C., the US. Prasco Laboratories is headquartered in Mason, Ohio, the US.

Prasco LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Prasco LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Prasco LLC, Medical Devices Deals, 2012 to YTD 2018 9
Prasco LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Prasco LLC, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Prasco to Acquire Authorized Generic of Adderall XR Capsules from Teva Pharma and Shire 11
Partnerships 13
Prasco Lab Enters into Co-Marketing Agreement with Takeda Pharma 13
Prasco Labs Enters into Distribution Agreement with Recordati Rare Diseases 14
Prasco Labs Enters Into Distribution Agreement With Eli Lilly For Evista 15
Prasco Labs Enters Into Agreement With Shire For Distribution Of Fosrenol 16
Prasco Labs Enters Into Distribution Agreement With WellSpring Pharma For Phenoxybenzamine Hydrochloride Capsules 17
Prasco Labs Enters into Distribution Agreement with Sunovion Pharma for Xopenex 18
ViroPharma Enters Into Co-Marketing Agreement With Prasco Labs For Vancocin 19
Prasco Labs Enters Into Co-Marketing Agreement With Shire For Carbatrol 20
Asset Transactions 21
IGI Labs Acquires Econazole Nitrate Cream From Prasco 21
Acquisition 22
Prasco Laboratories Acquires Additional stake in Aprecia Pharma 22
Prasco LLC – Key Competitors 23
Prasco LLC – Key Employees 24
Prasco LLC – Locations And Subsidiaries 25
Head Office 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Prasco LLC, Pharmaceuticals & Healthcare, Key Facts 2
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Prasco LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Prasco LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Prasco LLC, Medical Devices Deals, 2012 to YTD 2018 9
Prasco LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Prasco to Acquire Authorized Generic of Adderall XR Capsules from Teva Pharma and Shire 11
Prasco Lab Enters into Co-Marketing Agreement with Takeda Pharma 13
Prasco Labs Enters into Distribution Agreement with Recordati Rare Diseases 14
Prasco Labs Enters Into Distribution Agreement With Eli Lilly For Evista 15
Prasco Labs Enters Into Agreement With Shire For Distribution Of Fosrenol 16
Prasco Labs Enters Into Distribution Agreement With WellSpring Pharma For Phenoxybenzamine Hydrochloride Capsules 17
Prasco Labs Enters into Distribution Agreement with Sunovion Pharma for Xopenex 18
ViroPharma Enters Into Co-Marketing Agreement With Prasco Labs For Vancocin 19
Prasco Labs Enters Into Co-Marketing Agreement With Shire For Carbatrol 20
IGI Labs Acquires Econazole Nitrate Cream From Prasco 21
Prasco Laboratories Acquires Additional stake in Aprecia Pharma 22
Prasco LLC, Key Competitors 23
Prasco LLC, Key Employees 24

List of Figures
Prasco LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Prasco LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Prasco LLC, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Prasco LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Parkson Retail Group Ltd:企業の戦略・SWOT・財務情報
    Parkson Retail Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Parkson Retail Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Gree Inc (3632):企業の財務・戦略的SWOT分析
    Gree Inc (3632) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Just Energy Group Inc. (JE):企業の財務・戦略的SWOT分析
    Just Energy Group Inc. (JE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Ford Motor Company:企業の戦略・SWOT・財務分析
    Ford Motor Company - Strategy, SWOT and Corporate Finance Report Summary Ford Motor Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Delta Corporation Limited:企業の戦略・SWOT・財務情報
    Delta Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Delta Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • bioMerieux SA (BIM)-医療機器分野:企業M&A・提携分析
    Summary bioMerieux S.A. (bioMerieux) designs, develops and manufactures diagnostic systems and reagents for physicians and biologists. The company offers diagnostic solutions such as instruments, reagents and software. bioMerieux products are used diagnosing and managing infectious diseases, cardiov …
  • Filinvest Development Corporation (FDC):企業の財務・戦略的SWOT分析
    Filinvest Development Corporation (FDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Diploma PLC (DPLM):企業の財務・戦略的SWOT分析
    Summary Diploma PLC (Diploma) is a supplier of technical products and services. The company operates through its business such as life sciences, seals and controls. Its life sciences segment supplies instrumentation, consumables, and related services to the healthcare and environmental industries. D …
  • Qiagen NV (QIA):企業の財務・戦略的SWOT分析
    Qiagen NV (QIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Clean Harbors, Inc. (CLH)-石油・ガス分野:企業M&A・提携分析
    Summary Clean Harbors, Inc. (Clean Harbors) is a provider of environmental, industrial and energy services. The company offers waste disposal and recycling, emergency response, chemical packing, field services, production services, exploration services, directional boring, lodging services and insit …
  • Gulf Investment Corporation:企業の戦略的SWOT分析
    Gulf Investment Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Lojas Renner S.A.:企業の戦略・SWOT・財務情報
    Lojas Renner S.A. - Strategy, SWOT and Corporate Finance Report Summary Lojas Renner S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • The National Petrochemical Co:企業の戦略的SWOT分析
    The National Petrochemical Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Pure Technologies Ltd:企業の戦略的SWOT分析
    Pure Technologies Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Yum China Holdings Inc (YUMC):企業の財務・戦略的SWOT分析
    Yum China Holdings Inc (YUMC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Associated Milk Producers Inc.:企業の戦略・SWOT・財務情報
    Associated Milk Producers Inc. - Strategy, SWOT and Corporate Finance Report Summary Associated Milk Producers Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Air China Limited:企業のM&A・事業提携・投資動向
    Air China Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Air China Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Westpac Banking Corporation:企業の戦略・SWOT・財務情報
    Westpac Banking Corporation - Strategy, SWOT and Corporate Finance Report Summary Westpac Banking Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Delphi Automotive Plc (APTV):企業の財務・戦略的SWOT分析
    Delphi Automotive Plc (APTV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Vast Resources Plc:企業の戦略・SWOT・財務情報
    Vast Resources Plc - Strategy, SWOT and Corporate Finance Report Summary Vast Resources Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆